Vendor, Durham, NC
Zymeron Corporation
UEI GAMMMRQ6QMN1, CAGE 7MVB7
5 awards and $3,021,978 obligated between January 3, 2024 and May 21, 2026, 100% under full and open competition, against 3.2 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Defense Health Agency | $3,249,978 |
| Department of the Army | $0 |
| National Institutes of Health | -$228,000 |
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 5 |
| Small Business Set Aside - Total | 5 |
| Definitive Contract | 4 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HT942524C0057Definitive Contract, September 12, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | Army Med Res Acq ActivityDefense Health Agency | DHA SBIR Direct Phase II H2D-0243 Rapid Sample Processing Device to Support Battlefield Wound Infection DiagnosticsNAICS 541715, PSC AN12 | $2,999,983 |
| HT942524P0034Purchase Order, February 13, 2024, Full and Open Competition After Exclusion of Sources, 4 offers | Army Med Res Acq ActivityDefense Health Agency | DHA STTR Phase 1 Medical Research and Development Purchase Order for "proposal H23C-002-0028 "development of Woundshield for Pseudomonas AerNAICS 541715, PSC AN11 | $249,995 |
| HT942523C0067Definitive Contract, April 16, 2025, Full and Open Competition After Exclusion of Sources, 5 offers | Army Med Res Acq ActivityDefense Health Agency | DHA Small Business Innovation Research Direct to Phase II Medical Research and Development Contract from Proposal H2D-0119 Title DevelopmentNAICS 541715, PSC AN12 | $0 |
| W81XWH22C0012Definitive Contract, January 3, 2024, Full and Open Competition After Exclusion of Sources, 1 offers | W4PZ USA Med RSCH Acquis ActDepartment of the Army | Zymeron'S DHA SBIR Phase II Development for a Novel Countermeasure, Radiodefender, as a Radioprotector for Hematopoietic Acute Radiation SynNAICS 541715, PSC AN11 | $0 |
| 75N93021C00035Definitive Contract, March 13, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NiaidNational Institutes of Health | Bilateral Agreement to Accelerate the Completion Date.NAICS 541714, PSC AN14 | -$228,000 |
- Places of performance
- North Carolina
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied ResearchAN11 Health R&D Services; Health Care Services; Basic ResearchAN14 Health R&D Services; Health Care Services; R&D Administrative Expenses
- Transactions
- 9 across 5 awards